Mutations in the ST7/RAYI/HELG locus rarely occur in primary colorectal, gastric, and hepatocellular carcinomas

• Published in: British journal of cancer Vol. 88; no. 12; pp. 1909 - 1913
• Main Authors: Yoshimura, S, Yamada, T, Ohwada, S, Koyama, T, Hamada, K, Tago, K, Sakamoto, I, Takeyoshi, I, Ikeya, T, Makita, F, Iino, Y, Morishita, Y
• Format: Journal Article
• Language: English
• Published: 16-06-2003
• ISSN: 0007-0920
• DOI: 10.1038/sj.bjc.6600942

Human cancers frequently show a loss of heterozygosity on chromosome 7q31, which indicates the existence of broad-range tumour-suppressor gene(s) at this locus. Truncating mutations in the ST7 gene at this locus are seen frequently in primary colon cancer and breast cancer cell lines. Therefore, the ST7 gene represents a novel candidate gene for the tumour suppressor at this locus. However, more recent studies have reported that ST7 mutations are infrequent or absent in primary cancer and cell lines. To ascertain the frequency of mutations of the ST7 gene in cancer cells, we examined mutations in the ST7 coding sequence in 48 colorectal, 48 gastric, and 48 hepatocellular carcinomas using polymerase chain reaction-single-strand conformational polymorphism and direct sequencing. We detected somatic mutations, which were located near the exon-intron junction in intron 8, in only three out of 144 cases. We conclude that mutations in the ST7 gene are rare in primary colorectal, gastric, and hepatocellular carcinomas.